Search

Projects

Understanding post-COVID-19 illegal wildlife-based medicine consumption to inform effective interventions

 

Key Facts

FUNDING SCHEME ICON
FUNDING SCHEME
Covid19 Rapid Response
VALUE ICON
VALUE
£30,859
WHERE ICON
WHERE
China

Summary

This project will compare unique pre-COVID-19 baseline data to post-COVID-19 surveys and interviews with the public, consumers, and medical practitioners, to look at how bear bile consumption has changed in China during the pandemic. It will also collect data on pandemic-related consumption of key illegal wildlife-based medicines (e.g. tiger bone). This will identify high-risk consumer groups, who will participate in co-design workshops, developing prototype interventions to reduce illegal wildlife consumption in post-COVID-19 China, and in other countries with similar markets.
 
Status Completed
Reference CV19RR07
Round 26
Start 01/01/2021
End 31/03/2021


Regions
East Asia

Countries
China

Documents:
Download: Final Report - CV19RR07 FR (Public Version) - 07/01/2022

Download: Application Form - CV19RR07 App - 18/02/2021